Literature DB >> 8702930

Reduced requirement of mitogen-activated protein kinase (MAPK) activity for entry into the S phase of the cell cycle in Swiss 3T3 fibroblasts stimulated by bombesin and insulin.

T Seufferlein1, D J Withers, E Rozengurt.   

Abstract

Bombesin induced a marked and persistent activation of the mitogen-activated protein kinase kinase-1 (MEK-1), p42(mapk) and p90(rsk) in Swiss 3T3 cells by a pathway that was independent of p74(raf-1) but dependent on the activity of protein kinase C. Pretreatment of the cells with a specific inhibitor of MEK-1, PD 098059, markedly reduced the early and abolished the sustained phase of bombesin-induced p42(mapk) activation. In addition, PD 098059 prevented bombesin-induced DNA synthesis and progression of the cells through the cell cycle, indicating that the mitogenic effect of bombesin is dependent on the activation of p42(mapk). However, in the presence of insulin, which neither stimulated p42(mapk) activation nor DNA synthesis on its own in Swiss 3T3 cells, bombesin potently stimulated DNA synthesis even at concentrations of PD 098059 (15 microM) that completely abolished the mitogenic effect of bombesin alone. Furthermore, Swiss 3T3 cells stably transfected with interfering mutants of MEK-1 showed a marked decrease in the mitogenic effect of bombesin. In contrast, the combination of bombesin and insulin strongly stimulated DNA synthesis in these cells to levels comparable with that obtained in the wild type cells. Thus, our data demonstrate that insulin dramatically reduced the requirement for the mitogen-activated protein kinase pathway for reinitiation of DNA synthesis in bombesin-treated Swiss 3T3 cells and consequently indicate that the contribution of the mitogen-activated protein kinase cascade to mitogenesis depends on the combination of extracellular signals that are used to stimulate these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702930     DOI: 10.1074/jbc.271.35.21471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Ethanol potentiates the stimulatory effects of insulin and phosphocholine on mitogenesis by a zinc-dependent and rapamycin-sensitive mechanism in fibroblasts and JB6 cells.

Authors:  Z Kiss; W H Anderson; J J Mukherjee
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.

Authors:  A J Smith; R M McKernan
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.

Authors:  E Némoz-Gaillard; M Cordier-Bussat; C Filloux; J C Cuber; E Van Obberghen; J A Chayvialle; J Abello
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Dissociation of mitogen-activated protein kinase activation from p125 focal adhesion kinase tyrosine phosphorylation in Swiss 3T3 cells stimulated by bombesin, lysophosphatidic acid, and platelet-derived growth factor.

Authors:  T Seufferlein; D J Withers; D Mann; E Rozengurt
Journal:  Mol Biol Cell       Date:  1996-12       Impact factor: 4.138

5.  Mek2 is dispensable for mouse growth and development.

Authors:  Louis-François Bélanger; Sophie Roy; Michel Tremblay; Barbara Brott; Ann-Muriel Steff; Walid Mourad; Patrice Hugo; Raymond Erikson; Jean Charron
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 6.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

Review 7.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

8.  PRAK interacts with DJ-1 and prevents oxidative stress-induced cell death.

Authors:  Jing Tang; Jinghua Liu; Xue Li; Yuyun Zhong; Tianyu Zhong; Yawei Liu; Jiang Huai Wang; Yong Jiang
Journal:  Oxid Med Cell Longev       Date:  2014-10-14       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.